Form Type: 4

SEC EDGAR Link
Accession Number:0001824720-21-000002
Date:2021-06-03
Issuer: MYRIAD GENETICS INC (MYGN)
Original Submission Date:

Reporting Person:

KUMAR RASHMI
320 WAKARA WAY
SALT LAKE CITY, UT 84108

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-06-03 A 12,848 a $0.00 36,771 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 consists of restricted stock units granted pursuant to myriad genetics, inc.'s 2017 employee, director and consultant equity incentive plan. each restricted stock unit represents a contingent right to receive one share of common stock and vests on the anniversary of the date of grant.
WhaleWisdom Logo

Elevate your investments